InvestSMART

Biome Australia Limited (ASX:BIO)

ALERT: Price-sensitive ASX Announcement for BIO
Current share price for BIO : $0.365 0.02 (5.80%)+
Announcement
Release
9 Sep 2026 8:34AM
Price at Release
$0.345
Full Release
download
Summary
Biome Australia Limited (ASX: BIO) announced that it will launch two new Activated Probiotics products in H1 FY27, being Biome Daily Probiotic 60 and Biome Daily Kids Probiotic 60, which are two-month pack formats of its highest-volume probiotic lines; the company said the products are clinically supported for digestive and immune health, antibiotic-related gut support and common cold support, use microencapsulation technology designed to deliver more live bacteria to the gut, and build on the strong market position of the existing 30-pack products, with IQVIA data showing Biome Daily as the top probiotic product in Australian community pharmacy by units and value and Biome Daily Kids as the top immune health and children’s probiotic product; Biome said the larger pack size aligns with category demand where most leading probiotic products are 60 or 90 packs, is intended to improve adherence and retention, simplify recommendations for pharmacists and practitioners, increase transaction value, spread demand across more SKUs to reduce supply risk, and support gross margin improvement as manufacturing shifts onshore, with the new launches also marking Biome’s first Australian-made products under its manufacturing agreement with Specialty Probiotics Australia, while the company expects new sales growth to exceed any substitution from the existing 30-pack formats and provided no revenue guidance for the launch.
Key Points
  • Biome will launch Biome Daily Probiotic 60 and Biome Daily Kids Probiotic 60 in H1 FY27.
  • The new products are two-month formats of Biome’s two highest-volume Activated Probiotics products.
  • Biome Daily is positioned for digestive and immune health, while Biome Daily Kids supports immune function and healthy gut bacteria during antibiotic use.
  • Both products use microencapsulation technology that the company says helps five times more live bacteria reach the gut than uncoated probiotics.
  • IQVIA data cited in the announcement ranks Biome Daily as the number one probiotic product in Australian pharmacy by units and value.
  • IQVIA data cited in the announcement ranks Biome Daily Kids as the number one immune health and kids probiotic product.
  • Biome said 14 of the top 20 probiotic products in Australian pharmacy are sold in 60 or 90 pack formats.
  • The company expects new sales from the 60-pack launches to run well ahead of any substitution from the 30-pack products.
  • The products will be supplied through existing pharmacy wholesalers and the practitioner channel during the first half of FY27.
  • The launches are intended to support adherence, simplify pharmacist and practitioner recommendations, and increase transaction value.
  • The new products will be Biome’s first Australian-made products under its onshore manufacturing agreement with Specialty Probiotics Australia.
  • Biome provided no revenue guidance for the new product launches.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.